Connect with us

Company News

SII becomes most valuable unlisted company of India

India’s largest vaccine manufacturing company Serum Institute of India has overtaken National Stock Exchange of India (NSE) as the most valuable unlisted company in India with a valuation of Rs 1.9 lakh crore, as per Hurun India’s 2022 Burgundy Private Hurun India 500 list.

The Hurun report is a list of the 500 most valuable non-state-owned companies in India, ranked according to their value, defined as market capitalization for listed companies, and valuations for non-listed companies. The cut-off date used for the special report is April 30, 2023.

As per the report,Serum Institute’s value declined by 13 per cent in the last six months. Pune based Serum Institute, headed by Adar Poonawalla, is one of the largest vaccine making companies in the world. It was founded by Cyrus Poonawalla in 1966 and is a part of Cyrus Poonawalla Group.

This was followed by National Stock Exchange of India at valuation of Rs 1.6 lakh crore and edtech startup Byju’s with a valuation of Rs 69,000 crore. Intas Pharma and Pharma Mankind are other two healthcare companies which have been named in the list report.

Furthermore, Reliance Industries has been named as the most valuable company in India, followed by Tata Consultancy Services, with a valuation of Rs 11.7 crore and HDFC Bank valuation at Rs 9.4 crore.

The value of RIL declined by Rs 87,731 crore, which is 5.1 per cent, in the last six months. Whereas, TCS value marginally surged by 0.7 per cent and HDFC Bank value increased by 12.9 per cent.

According to media reports, RIL is also the highest tax paying company with a payout of Rs 16,297 crore and one of the most profitable companies in India.

Of the 500 companies, 287 experienced a decline in total value, while 14 remained flat, and 24 dropped out of the list. The combined value of the top 10 companies remained flat at INR 71.4 lakh crore, representing a significant portion of India’s GDP.

“The total value of the top 500 companies in India declined marginally by 6.4 per cent to Rs 212 lakh crore from Rs 227 lakh crore as of October 30, 2022,” the report said.

“We are witnessing a unique confluence of events, with the Russia-Ukraine war causing a surge in inflationary pressures worldwide, central banks increasing their key lending rates and funding winter for startups. Amidst these challenging times, the companies featured in the Burgundy Private Hurun India 500 – Special Report, experienced a modest decline of 6.4% over the past six months,” said Anas Rahman Junaid MD and Chief Researcher, Hurun India. Jagran

Copyright © 2024 Medical Buyer

error: Content is protected !!